Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
Mov Disord ; 27(9): 1104-10, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22807207

ABSTRACT

Two genome-wide association studies (GWASs) recently highlighted the HLA-DRA and HLA-DRB5 genes as associated with Parkinson disease (PD). However, because HLA-DRA displays a low level of polymorphisms and HLA-DRB5 is only present in approximately 20% of the population, these findings are difficult to interpret. Our aims were: (1) to replicate and investigate in greater detail the association between PD and the HLA-DR region; (2) to identify PD-associated HLA alleles; and (3) to perform a meta-analysis of our top finding. As part of 2 French population-based case-control studies of PD including highly ethnically homogeneous participants, we investigated the association between PD and 51 Single-nucleotide polymorphisms (SNPs) in the HLA-DR region. HLA-DRB1 alleles were imputed using the HLA(*) IMP software. HLA typing was performed in a subsample of the participants. We performed a meta-analysis of our top finding based on 4 GWAS data sets. Among 499 cases and 1123 controls, after correction for multiple testing, we found an association with rs660895 (OR/minor allele, 0.70; 95% CI, 0.57-0.87) within the HLA-DRB1 gene, which encodes the most polymorphic HLA-DR chain (DRß). A meta-analysis (7996 cases, 36455 controls) confirmed this association (OR, 0.86; 95% CI, 0.82-0.91; P < .0001). SNP-based imputation of HLA alleles showed an inverse association between PD and the HLA-DRB1(*) 04 allele. We replicated an association between PD and the HLA-DR region and provided further insight into the loci and alleles involved. The highly polymorphic HLA-DRB1 locus contains rs660895, which represents a more legitimate candidate than previous ones. Our finding is in agreement with the hypothesis of an immune component in PD pathophysiology.


Subject(s)
HLA-DRB1 Chains/genetics , Parkinson Disease/genetics , Adult , Aged , Aged, 80 and over , DNA/genetics , Female , France/epidemiology , Genetic Predisposition to Disease , Genome-Wide Association Study , Genotype , Haplotypes , Humans , Male , Middle Aged , Parkinson Disease/epidemiology , Polymorphism, Single Nucleotide , Socioeconomic Factors
3.
Int J Cancer ; 128(11): 2591-601, 2011 Jun 01.
Article in English | MEDLINE | ID: mdl-20715114

ABSTRACT

Butyrate, a short-chain fatty acid produced by the colonic bacterial fermentation is able to induce cell growth inhibition and differentiation in colon cancer cells at least partially through its capacity to inhibit histone deacetylases. Since butyrate is expected to impact cellular metabolic pathways in colon cancer cells, we hypothesize that it could exert its antiproliferative properties by altering cellular metabolism. We show that although Caco2 colon cancer cells oxidized both butyrate and glucose into CO(2) , they displayed a higher oxidation rate with butyrate as substrate than with glucose. Furthermore, butyrate pretreatment led to an increase cell capacity to oxidize butyrate and a decreased capacity to oxidize glucose, suggesting that colon cancer cells, which are initially highly glycolytic, can switch to a butyrate utilizing phenotype, and preferentially oxidize butyrate instead of glucose as energy source to produce acetyl coA. Butyrate pretreated cells displayed a modulation of glutamine metabolism characterized by an increased incorporation of carbons derived from glutamine into lipids and a reduced lactate production. The butyrate-stimulated glutamine utilization is linked to pyruvate dehydrogenase complex since dichloroacetate reverses this effect. Furthermore, butyrate positively regulates gene expression of pyruvate dehydrogenase kinases and this effect involves a hyperacetylation of histones at PDK4 gene promoter level. Our data suggest that butyrate exerts two distinct effects to ensure the regulation of glutamine metabolism: it provides acetyl coA needed for fatty acid synthesis, and it also plays a role in the control of the expression of genes involved in glucose utilization leading to the inactivation of PDC.


Subject(s)
Adenocarcinoma/metabolism , Butyrates/pharmacology , Cell Differentiation/drug effects , Cell Proliferation/drug effects , Colonic Neoplasms/metabolism , Pyruvate Dehydrogenase Complex/metabolism , Adenocarcinoma/drug therapy , Blotting, Western , Chromatin Immunoprecipitation , Colonic Neoplasms/drug therapy , Glucose/metabolism , Glutamine/metabolism , Glycolysis , Histone Deacetylases/chemistry , Histone Deacetylases/metabolism , Histones/metabolism , Humans , Oxidation-Reduction , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Pyruvate Dehydrogenase Acetyl-Transferring Kinase , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured
4.
Biochimie ; 92(12): 1772-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20691246

ABSTRACT

The polyunsaturated fatty acid (PUFA) docosahexaenoic acid (DHA) reduces proliferation of several cell types, including colon tumor cells, and regulates gene expression in a cell- and gene-selective manner. In hepatocytes, the fatty acid synthase (FAS) gene is down-regulated by DHA whereas the carnitine palmitoyltransferase-1 (CPT-1) gene is up-regulated. In adipocytes but not in hepatocytes, the expression of the cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) gene is stimulated by unsaturated FA, including DHA. We monitored the expression of the FAS, CPT-1 and PEPCK-C genes in rat and human colon and in colonic tumors from humans. The ratio of PEPCK-C to FAS transcripts was in favor of PEPCK-C in human and rat colon, whereas the opposite occurred in Caco2 tumoral cells. FAS gene expression declined from proliferative to differentiated Caco2 cells, while in contrast the expression of PEPCK-C and CPT-1 genes increased. DHA strongly induced expression of the PEPCK-C and CPT-1 genes, in correlation with decreased cell growth, while, as expected, it reduced FAS mRNA. We assessed the relative expression of PEPCK-C, CPT-1 and FAS genes in fragments of colonic tumors and adjacent non-tumoral tissue from a series of 10 patients. PEPCK-C and CPT-1 mRNAs are more abundant in non-tumoral tissues than in the tumoral counterpart, whereas the opposite occurred for the FAS gene. Therefore, the PEPCK-C gene can be defined as a new negative marker for colonic tumors and a target for the anti-tumorigenic action of omega-3 PUFAs.


Subject(s)
Colonic Neoplasms/genetics , Fatty Acids, Omega-3/pharmacology , Gene Expression Profiling , Phosphoenolpyruvate Carboxylase/genetics , Adipose Tissue/enzymology , Adipose Tissue/metabolism , Aged , Animals , Caco-2 Cells , Carnitine O-Palmitoyltransferase/genetics , Cell Differentiation/genetics , Cell Proliferation/drug effects , Colon/enzymology , Colon/metabolism , Colonic Neoplasms/enzymology , Colonic Neoplasms/pathology , Docosahexaenoic Acids/pharmacology , Dose-Response Relationship, Drug , Down-Regulation/drug effects , Fatty Acid Synthases/genetics , Female , Gene Expression Regulation, Enzymologic/drug effects , Gene Expression Regulation, Neoplastic/drug effects , Humans , Male , Middle Aged , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction
5.
Exp Cell Res ; 314(11-12): 2199-211, 2008 Jul 01.
Article in English | MEDLINE | ID: mdl-18570918

ABSTRACT

The Cystic Fibrosis Transmembrane conductance Regulator (CFTR) protein is a chloride channel localized at the apical plasma membrane of epithelial cells. We previously described that syntaxin 8, an endosomal SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) protein, interacts with CFTR and regulates its trafficking to the plasma membrane and hence its channel activity. Syntaxin 8 belongs to the endosomal SNARE complex which also contains syntaxin 7, vti1b and VAMP8. Here, we report that these four endosomal SNARE proteins physically and functionally interact with CFTR. In LLC-PK1 cells transfected with CFTR and in Caco-2 cells endogenously expressing CFTR, we demonstrated that endosomal SNARE protein overexpression inhibits CFTR activity but not swelling- or calcium-activated iodide efflux, indicating a specific effect upon CFTR activity. Moreover, co-immunoprecipitation experiments in LLC-PK1-CFTR cells showed that CFTR and SNARE proteins belong to a same complex and pull-down assays showed that VAMP8 and vti1b preferentially interact with CFTR N-terminus tail. By cell surface biotinylation and immunofluorescence experiments, we evidenced that endosomal SNARE overexpression disturbs CFTR apical targeting. Finally, we found a colocalization of CFTR and endosomal SNARE proteins in Rab11-positive recycling endosomes, suggesting a new role for endosomal SNARE proteins in CFTR trafficking in epithelial cells.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Epithelial Cells/metabolism , Qa-SNARE Proteins/metabolism , Qb-SNARE Proteins/metabolism , R-SNARE Proteins/metabolism , SNARE Proteins/metabolism , Animals , Cell Line , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Endosomes/metabolism , Epithelial Cells/cytology , Humans , Iodides/metabolism , Protein Transport/physiology , Qa-SNARE Proteins/genetics , Qb-SNARE Proteins/genetics , R-SNARE Proteins/genetics , RNA Interference , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , SNARE Proteins/genetics , rab GTP-Binding Proteins/genetics , rab GTP-Binding Proteins/metabolism
6.
J Cell Sci ; 117(Pt 10): 1923-35, 2004 Apr 15.
Article in English | MEDLINE | ID: mdl-15039462

ABSTRACT

The cystic fibrosis transmembrane conductance regulator (CFTR) is a cyclic AMP-dependent chloride channel that mediates electrolyte transport across the luminal surface of epithelial cells. In this paper, we describe the CFTR regulation by syntaxin 8, a t-SNARE protein (target soluble N-ethylmaleimide-sensitive factor attachment protein receptor) involved in the SNARE endosomal complex. Syntaxin family members are key molecules implicated in diverse vesicle docking and membrane fusion events. We found that syntaxin 8 physically interacts with CFTR: recombinant syntaxin 8 binds CFTR in vitro and both proteins co-immunoprecipitate in HT29 cells. Syntaxin 8 regulates CFTR-mediated currents in chinese hamster ovary (CHO) cells stably expressing CFTR and syntaxin 8. Iodide efflux and whole-cell patch-clamp experiments on these cells indicate a strong inhibition of CFTR chloride current by syntaxin 8 overexpression. At the cellular level, we observed that syntaxin 8 overexpression disturbs CFTR trafficking. Confocal microscopy shows a dramatic decrease in green fluorescent protein-tagged CFTR plasma membrane staining, when syntaxin 8 is coexpressed in COS-7 cells. Using antibodies against Lamp-1, TfR or Rab11 we determined by immunofluorescence assays that both proteins are mainly accumulated in recycling endosomes. Our results evidence that syntaxin 8 contributes to the regulation of CFTR trafficking and chloride channel activity by the SNARE machinery.


Subject(s)
Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Membrane Proteins/physiology , Animals , Antigens, CD/metabolism , Antigens, Surface/metabolism , CHO Cells , COS Cells , Cell Line , Cricetinae , DNA, Complementary/metabolism , Electrophoresis, Polyacrylamide Gel , Endosomes/metabolism , Glutathione Transferase/metabolism , Humans , Immunoblotting , Immunoprecipitation , Iodides/chemistry , Lysosomal Membrane Proteins , Membrane Proteins/metabolism , Microscopy, Confocal , Microscopy, Fluorescence , Nerve Tissue Proteins/metabolism , Patch-Clamp Techniques , Protein Binding , Protein Transport , Qa-SNARE Proteins , Receptors, Transferrin/metabolism , Signal Transduction , Syntaxin 1 , Time Factors , Transfection , rab GTP-Binding Proteins/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...